Clinical Trials Logo

Filter by:
NCT ID: NCT04292730 Completed - COVID-19 Clinical Trials

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment

Start date: March 15, 2020
Phase: Phase 3
Study type: Interventional

The primary objective of this study was to evaluate the efficacy of 2 remdesivir (RDV) regimens compared to standard of care (SOC), with respect to clinical status assessed by a 7-point ordinal scale on Day 11.

NCT ID: NCT04290260 Completed - Wound Healing Clinical Trials

Use of the Bra as Prevention of Sternal Wound Dehiscence in Cardiac Surgery

DEHISCENCIA
Start date: January 2015
Phase: N/A
Study type: Interventional

The aim of the study was to assess the efficacy of bra application as a prevention of dehiscence in women with median sternotomy.

NCT ID: NCT04290221 Completed - Clinical trials for Chronic Low-back Pain

Effectiveness Analysis of Ultrasound-guided Intratissue Percutaneous Electrolysis (EPI) in Patient With Chronic Low Back Pain

Start date: November 30, 2021
Phase: N/A
Study type: Interventional

The main objective of this study is to analyze the effectiveness of the lumbar nerve root stimulation with ultrasound-guided percutaneous electrolysis versus the electrical dry needling of trigger points in patients with chronic low back pain.

NCT ID: NCT04289896 Completed - Football Player Clinical Trials

Plyometric Training, in the Improvement of Explosive Strength and Speed in Soccer Players

Start date: March 2, 2020
Phase: N/A
Study type: Interventional

Football requires a high number of actions at high speed and intensity. The application of plyometrics can improve explosive strength and speed levels in soccer players. The main objective of the study is to assess the effectiveness of a program based on plyometric exercises for the improvement of the explosive force in vertical jump and the speed in running with and without the ball in soccer players of youth category. Randomized clinical study, simple blind, with follow-up period. 30 players will be randomized to the study groups: experimental and control. The intervention will last 4 weeks, with 2 weekly sessions lasting 20 minutes. The study variables will be: Vertical Countermovement Jump Test with Arms and Twenty-Centimeter Drop Jump Reactive Strength Index (Explosive Force), running speed without ball and ball (20 meter speed test), hitting speed of ball (Maximal Kicking Velocity Test), hamstring extensibility (Sit and Reach Test) and sural triceps extensibility (Leg Motion Basic). Normality will be calculated using an analysis of Kolmogorov Smirnov. With the t-student test the differences between assessments will be calculated and with an ANOVA of repeated measures, the effect between intersubject will be calculated. The effect size will be obtained with Cohen's formula. It is expected to obtain an improvement in the explosive force in the vertical jump, as well as in the running speed with and without the ball.

NCT ID: NCT04289194 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome

Start date: December 10, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The main objective of the study is to assess the feasibility, safety, and tolerability of the administration of HCR040, a drug whose active substance is HC016, allogeneic adipose-derived adult mesenchymal stem cells expanded and pulsed with H2O2, in patients with acute respiratory distress syndrome.

NCT ID: NCT04288908 Completed - General Population Clinical Trials

Trait Injustice, Social Exclusion, and Anger

Start date: January 5, 2020
Phase: N/A
Study type: Interventional

Participants will be randomly allocated to one of two experimental conditions: social exclusion or social inclusion. Participants, but not experimenters will be blind to the assignment. Pre- and post-tests will be administered. Participants will be offered 7 euros in compensation for participating.

NCT ID: NCT04287985 Completed - Clinical trials for Immunoglobulin A Nephropathy

Safety and Efficacy Study of VIS649 for IgA Nephropathy

Start date: July 20, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of VIS649 in participants with immunoglobulin A (IgA) Nephropathy (IgAN)

NCT ID: NCT04287777 Completed - Impetigo Clinical Trials

Safety and Efficacy of Mupirocin Gel in Children With Impetigo

Start date: February 2014
Phase: Phase 3
Study type: Interventional

The purpose of the study is to show non inferiority in terms of safety and efficacy of topical administration BID (Twice daily) of Mupirocin Gel 20 mg/g compared to topical administration of Mupirocin Ointment 20 mg/g TID (three times daily) (Bactroban) in the treatment of impetigo in paediatric population.

NCT ID: NCT04286646 Completed - Pupillary Disorders Clinical Trials

Correlation of Pupillary Diameter Changewith Age and Anterior Chamber Depth After Cataract Surgery

Start date: May 20, 2018
Phase:
Study type: Observational

PURPOSE: To assess the correlation between the change in pupil diameter, age and depth of the anterior chamber after 3 months of cataract surgery both in photopic and mesopic conditions. And study the changes of the pupillary diameter at 3 months after surgery in the two light conditions

NCT ID: NCT04286022 Completed - Clinical trials for Neuromuscular Adaptations

Specific Neurotechnical Strength Training (NeuroTraining)

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This study aims to apply a novel study methodology using high density electromyography (HDEMG) to know what are the mechanisms underlying the structural and functional changes obtained by two different training methods, commonly used, facilitating their understanding, study and subsequent application according to specific needs.